Pablo Legorreta

Pablo Legorreta is founder and CEO of Royalty Pharma. Formed in 1996, Royalty Pharma is the industry leader in acquiring revenue-producing intellectual property in life sciences from the original innovators (academic institutions, research hospitals, foundations and inventors) or biotech companies.

Previously, Legorreta spent 10 years at Lazard Freres, where he provided cross-border merger-and-acquisition and corporate finance advisory services to U.S. and European corporations. He serves on the board of governors of the New York Academy of Sciences and the boards of the Pasteur Foundation (U.S. affiliate of the French Institut Pasteur), the Open Medical Institute and the Park Avenue Armory.

Legorreta serves on the Board of Directors of Epizyme (Nasdaq: EPZM) and on the Board of Governors of the New York Academy of Sciences, as well as the Boards of Trustees of Rockefeller University, Brown University, the Hospital for Special Surgery, Pasteur Foundation, Open Medical Institute and Park Avenue Armory.

He also founded and is chairman of Alianza Médica para la Salud, a privately funded, not-for-profit foundation whose goal is to educate Latin American doctors and health-care providers to improve the quality of health care in Latin America. Legorreta received a degree in industrial engineering from Universidad Iberoamericana.